Skip to content
10-K

Annual Report

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

0001493152-24-014975

← back to feed
Filed
Apr 17, 2024 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 15, 2024 4.23B sh
Shares Diluted FY 2023 · Dec 31, 2023 3.17B sh
Shares Diluted FY 2023 · Dec 31, 2022 2.53B sh
Capex FY 2023 · Dec 31, 2023 $16.16K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$1.06M
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$1.04M
Cash And Equivalents FY 2023 · Dec 31, 2023 $27.82K
Cash And Equivalents restated FY 2023 · Dec 31, 2022 $18.43K
Stockholders Equity FY 2023 · Dec 31, 2023 $1.13M
Stockholders Equity restated FY 2023 · Dec 31, 2022 $1.22M
Current Liabilities FY 2023 · Dec 31, 2023 $1.9M
Current Liabilities FY 2023 · Dec 31, 2022 $2.21M
Total Liabilities FY 2023 · Dec 31, 2023 $2.01M
Total Liabilities FY 2023 · Dec 31, 2022 $2.22M
Current Assets FY 2023 · Dec 31, 2023 $85.91K
Current Assets restated FY 2023 · Dec 31, 2022 $309.62K
Total Assets FY 2023 · Dec 31, 2023 $3.29M
Total Assets restated FY 2023 · Dec 31, 2022 $3.61M
Eps Diluted FY 2023 · Dec 31, 2023 $0.00
Eps Diluted FY 2023 · Dec 31, 2022 $0.00
Eps Basic FY 2023 · Dec 31, 2023 $0.00
Eps Basic FY 2023 · Dec 31, 2022 $0.00
Rd Expense FY 2023 · Dec 31, 2023 $560.65K
Rd Expense restated FY 2023 · Dec 31, 2022 $1.45M
Net Income FY 2023 · Dec 31, 2023 −$2.17M
Net Income restated FY 2023 · Dec 31, 2022 −$3.81M
Operating Income FY 2023 · Dec 31, 2023 −$1.99M
Operating Income restated FY 2023 · Dec 31, 2022 −$3.28M
Gross Profit FY 2023 · Dec 31, 2023 $62.23K
Gross Profit FY 2023 · Dec 31, 2022 $127.33K
Cost Of Revenue FY 2023 · Dec 31, 2023 $36.77K
Cost Of Revenue FY 2023 · Dec 31, 2022 $79.44K
Revenue FY 2023 · Dec 31, 2023 $98.99K
Revenue FY 2023 · Dec 31, 2022 $206.77K